Free Trial

Avalo Therapeutics (AVTX) Institutional Ownership

→ The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad)
Free AVTX Stock Alerts
$10.60
-0.22 (-2.03%)
(As of 05/14/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Avalo Therapeutics (NASDAQ:AVTX)

Current
Institutional Ownership
Percentage
87.06%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$229.08M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$45.50K
Get AVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AVTX Institutional Buying and Selling by Quarter

Avalo Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2024Affinity Asset Advisors LLC10,000$218K0.0%N/A0.971%
5/14/2024 Natixis2,512$55K0.0%-45.4%0.244%
11/13/2023 Acadian Asset Management LLC283,306$34K0.0%N/A1.399%
8/11/2023VR Adviser LLC1,250,000$444K0.1%+25.0%6.173%
5/16/2023Great Point Partners LLC474,639$831K0.2%N/A3.595%
5/5/2023Monashee Investment Management LLC60,000$105K0.0%N/A0.455%
2/15/2023Nantahala Capital Management LLC540,667$2.73M0.2%-1.3%5.746%
11/14/2022Armistice Capital LLC3,964,666$13.16M0.2%-91.7%42.115%
11/14/2022Point72 Asset Management L.P.500,737$1.66M0.0%-91.7%5.319%
11/10/2022Nantahala Capital Management LLC547,814$1.82M0.1%-91.8%5.819%
10/27/2022 Assenagon Asset Management S.A.15,646$52K0.0%N/A0.166%
8/15/2022Nantahala Capital Management LLC6,710,327$3.36M0.2%-2.0%71.280%
8/15/2022Opaleye Management Inc.450,000$225K0.1%-69.1%4.780%
5/12/2022Integral Health Asset Management LLC700,000$507K0.1%-56.9%0.621%
5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056%
4/25/2022 Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038%
2/15/2022Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344%
2/15/2022 LGL Partners LLC28,850$49K0.0%N/A0.026%
2/14/2022Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018%
2/14/2022Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686%
2/8/2022Northern Trust Corp533,578$907K0.0%+3.1%0.475%
2/1/2022 Assenagon Asset Management S.A.582,718$991K0.0%-33.7%0.519%
1/24/2022 Strs Ohio38,400$65K0.0%-40.2%0.034%
1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031%
12/29/2021Hudson Bay Capital Management LP197,133$430K0.0%N/A0.176%
11/16/2021Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299%
11/16/2021Squarepoint Ops LLC18,657$41K0.0%N/A0.017%
11/16/2021Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713%
11/16/2021Two Sigma Investments LP732,931$1.60M0.0%N/A0.653%
11/16/2021Laurion Capital Management LP330,444$720K0.0%N/A0.294%
11/15/2021Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350%
11/15/2021Atom Investors LP27,507$60K0.0%N/A0.024%
11/15/2021Voya Investment Management LLC21,854$48K0.0%N/A0.019%
11/15/2021 Caas Capital Management LP11,812$26K0.0%N/A0.011%
11/12/2021Aristides Capital LLC48,953$107K0.0%N/A0.044%
11/12/2021Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770%
11/12/2021 Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126%
11/12/2021Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473%
11/10/2021Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610%
11/10/2021 Creative Planning14,814$32K0.0%N/A0.013%
With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (Ad)

Revolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing.

See how this company is well-positioned to capitalize in 2024
11/10/2021Alliancebernstein L.P.19,100$42K0.0%N/A0.017%
11/9/2021 BlackRock Inc.3,716,943$8.10M0.0%N/A3.369%
11/9/2021Monashee Investment Management LLC270,000$589K0.1%N/A0.245%
11/8/2021 Meeder Asset Management Inc.19,260$43K0.0%N/A0.017%
11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485%
11/4/2021Deutsche Bank AG31,794$69K0.0%N/A0.029%
11/2/2021 Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011%
11/2/2021 New York State Common Retirement Fund22,214$48K0.0%N/A0.020%
11/2/2021 Victory Capital Management Inc.15,788$34K0.0%N/A0.014%
11/1/2021 SG Americas Securities LLC18,596$41K0.0%N/A0.017%
10/29/2021Commonwealth Equity Services LLC52,000$113K0.0%N/A0.047%
10/25/2021Minot Wealth Management LLC103,410$225K0.0%N/A0.094%
10/22/2021 Strs Ohio64,200$139K0.0%N/A0.058%
10/19/2021 Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797%
10/19/2021 Tamar Securities LLC23,084$50K0.0%N/A0.021%
(Data available from 1/1/2016 forward)

AVTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AVTX shares?

During the previous two years, 11 institutional investors and hedge funds held shares of Avalo Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($13.16M), Nantahala Capital Management LLC ($2.73M), Point72 Asset Management L.P. ($1.66M), Great Point Partners LLC ($831K), VR Adviser LLC ($444K), Opaleye Management Inc. ($225K), and Affinity Asset Advisors LLC ($218K).Learn more on AVTX's institutional investors.

What percentage of Avalo Therapeutics stock is owned by institutional investors?

87.06% of Avalo Therapeutics stock is owned by institutional investors. Learn more on AVTX's institutional investor holdings.

Which institutional investors have been buying Avalo Therapeutics stock?

The following institutional investors have purchased Avalo Therapeutics stock in the last 24 months: Great Point Partners LLC ($474.64K), Acadian Asset Management LLC ($283.31K), VR Adviser LLC ($250K), Monashee Investment Management LLC ($60K), Assenagon Asset Management S.A. ($15.65K), and Affinity Asset Advisors LLC ($10K).

How much institutional buying is happening at Avalo Therapeutics?

Institutional investors have bought a total of 1,093,591 shares in the last 24 months. This purchase volume represents approximately $266.75M in transactions.

Which Avalo Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Avalo Therapeutics stock in the last 24 months: Armistice Capital LLC ($43.61M), Nantahala Capital Management LLC ($6.31M), Point72 Asset Management L.P. ($5.51M), Opaleye Management Inc. ($1.00M), and Natixis ($2.09K).

How much institutional selling is happening at Avalo Therapeutics?

Institutional investors have sold a total of 56,434,819 shares in the last 24 months. This volume of shares sold represents approximately $45.70B in transactions.


Related Companies:
This page (NASDAQ:AVTX) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar
Stocks News
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Gold Set to EXPLODE!
Gold Safe Exchange
The Crypto 9-5 Escape Plan
Crypto 101 Media
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Buy this small stock before coming AI Tidal Wave
Chaikin Analytics
Elon’s New Device is About to Shock the World
InvestorPlace